Phase 2b Elumina trial; topline data anticipated in Q4 2026 (ClinicalTrials.gov: NCT06524830) AtaiBeckley plans to advance VLS-01 into major depressive disorder (MDD) in Phase 3, with generalized ...
The United States’ 250th birthday carries ambitions to galvanize Americans behind nationwide community-service drives and ...
Want to design embroidery pattern files (PES, DST, and many more) using free, open source software? Ink/Stitch aims to be a full-fledged embroidery digitizing platform based entirely on free, open ...